Cite
MLA Citation
Ugo De Giorgi et al.. “Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region.” European journal of cancer, vol. 159, 2021, pp. 237–246. http://access.bl.uk/ark:/81055/vdc_100146760833.0x000032